Back

Prognosis and evaluation of the risk markers of arrhythmia in a large population of Brugada syndrome patients

3 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Channelopathies - from all to bedside Brugada Syndrome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mrs Soraya Anys

University Hospital of Nantes, Nantes (France)

6 More presentations in this session

Presentation thumbnail
A mutation specific prediction model for ventricular arrhythmias in the phospholamban (PLN) p.Arg14del cardiomyopathy
Mr T. Verstraelen (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Pathogenic mechanism of DSG2-F531C mutation caused arrhythmogenic right ventricular cardiomyopathy
Doctor D. Wang (Nanjing, CN)
Abstract
Presentation thumbnail
Structural insights into catecholaminergic polymorphic ventricular tachycardia-associated RyR2 mutant channels using a three-dimensional in silico model
Mr J. Gao (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Diagnostic yield in victims of sudden cardiac death and their relatives
Mr B. Hansen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Shanghai score system into practice.
Doctor P. Carvalho (Orbassano, IT)
Abstract Slides

Access the full session

Session thumbnail
Channelopathies - from all to bedside

The Event

Event poster

ESC Congress 2019

3 September 2019 10:05 CET
You may be interested in
thumbnail
Congress Session
Ventricular arrhythmias and prevention of sudden cardiac death (6)
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
Live-in-the-Box: ablation of ventricular fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources